FRAMINGHAM (02/27/2004) - University of Cambridge spinoff Paradigm Therapeutics Ltd.'s latest venture opened last month in Biopolis, a new biomedical research and development facility in Singapore. Joining the company from GlaxoSmithKline PLC, Ian Gray will lead Paradigm Therapeutics Singapore as head of research. Back in the U.S., Paradigm recently named Mark Carlton CEO and Edwin Moses non-executive chairman.
- Free Whitepaper! Learn how to create an analytics environment that is governed, scalable and self-serve.
- Free Whitepaper! Learn how IT is evolving from producer to enabler, and fostering collaboration around analytics.
- Free Whitepaper! The 5 criteria to help you select the right analytics platform for your organization.